|
MEX3C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.040120E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.515120E-03 |
| Normal-vs-Stage2 |
4.029800E-01 |
| Normal-vs-Stage3 |
1.906610E-01 |
| Normal-vs-Stage4 |
4.759900E-02 |
| Stage1-vs-Stage2 |
3.075100E-03 |
| Stage1-vs-Stage3 |
1.187200E-01 |
| Stage1-vs-Stage4 |
7.404400E-01 |
| Stage2-vs-Stage3 |
6.683800E-02 |
| Stage2-vs-Stage4 |
1.997800E-02 |
| Stage3-vs-Stage4 |
3.920800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.276500E-03 |
| Normal-vs-AfricanAmerican |
6.615700E-02 |
| Normal-vs-Asian |
4.001900E-03 |
| Caucasian-vs-AfricanAmerican |
5.737600E-01 |
| Caucasian-vs-Asian |
2.195800E-01 |
| AfricanAmerican-vs-Asian |
7.671200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.125970E-01 |
| Normal-vs-Female |
7.543900E-03 |
| Male-vs-Female |
4.311600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.755140E-04 |
| Normal-vs-Age(41-60Yrs) |
1.262630E-01 |
| Normal-vs-Age(61-80Yrs) |
7.829000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.915600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.202200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.998290E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.683600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.253700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.173600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.542000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.748200E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
2.809600E-01 |
| Classical-VS-Normal |
4.82530000001091E-06 |
| Tall-VS-Follicular |
1.67159999953093E-07 |
| Tall-VS-Other |
3.546400E-01 |
| Tall-VS-Normal |
8.977800E-03 |
| Follicular-VS-Other |
6.221500E-02 |
| Follicular-VS-Normal |
6.395900E-04 |
| Other-VS-Normal |
7.658000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.210400E-01 |
| Normal-vs-N1 |
1.651660E-02 |
| N0-vs-N1 |
1.203820E-02 |
|
|
